Learn About - Closed Studies

Study

Type of Research

Status

SURE-PD3 Neuroprotective Agent

Enrollment closed

In follow-up

STEADY-PD3 Neuroprotective Agent

Enrollment closed

In follow-up

AADC Gene Therapy for PD Gene Therapy

Enrollment closed 

In follow-up

VY-AADC01 Gene Therapy for PD Gene Therapy

Enrollment closed

In follow-up

Cerebrospinal Fluid Biomarkers in PD Imaging, Biomarkers

Enrollment closed 

In follow-up

FS ZONE - Study of Pioglitazone as a neuroprotective agent Neuroprotective Agent

Enrollment closed

In follow-up

Phase II - SYN115 Medication for "wearing off"

Enrollment closed

In follow-up

Recognizing atypical forms of PD  Imaging study

Enrollment closed

In follow-up

Study of Cerebral Potentials in Parkinson's disease Electrophysiological Study

Enrollment closed 

In follow-up

NET-PD: Creatine

Neuroprotective Agent

 

Study Terminated. More info here.

Phase II Neurturin Gene Therapy

Enrollment closed

In follow-up

Phase I Study of AADC

Gene Therapy

Enrollment closed

In follow-up

Computer game (Wii) for gait and balance training

Physical therapy

Enrollment closed

In follow-up

The effects of the rivastigmine patch on attention and behavior in PD with dementia

Medication for Cognitive Symptoms

Enrollment closed

In follow-up

Antidepressants in PD (SAD-PD)

Comparison of medications

Completed

PramiBID - Mirapex

Optimal dosage of medication

Completed

PROGENI

Genetics in PD

Completed

Quantitative Motor Assessment Tool (QMAT)

Diagnostic device for PD

Completed

fMRI Study of PD and Working Memory

Imaging

Enrollment closed

Parkinsons Disease Signature Imaging

Imaging, Biomarkers

Enrollment closed

Domain-specific tasks of executive function in PD

Cognitive study

Enrollment closed

Spatial cognition in neurodegenerative disease

Cognitive study

Enrollment closed

*Click on links for more information on these studies